Current Status of Desonide in the Market
Desonide is a topical corticosteroid used to treat various skin conditions such as eczema, atopic dermatitis, and psoriasis [1]. Despite being a well-established medication, its market dynamics have undergone significant changes in recent years.
Competition and Biosimilars
Several companies, including Mylan, Sandoz, and Lupin, have developed biosimilars of desonide, which could potentially compete with the original product [2]. Biosimilars are biologically similar versions of original biologic drugs that offer lower prices and increased accessibility.
Patent Expiration and Generic Options
According to DrugPatentWatch.com, the patent for desonide expired in 2019, allowing generic versions to enter the market [3]. This has led to increased competition and reduced prices for the medication.
Market Size and Growth
The global topical corticosteroid market, which includes desonide, is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2020 to 2027 [4]. The increasing demand for skin care products and the rising prevalence of skin conditions are driving this growth.
Patient Concerns and Side Effects
Patients with skin conditions may experience side effects when using desonide, such as skin dryness, itching, or redness [5]. It is essential for patients to carefully follow the recommended dosage and consult their doctor if they experience any adverse effects.
Manufacturing and Distribution
Desonide is manufactured by various companies, including Glenmark Pharmaceuticals and Pfizer [6]. The medication is available in different formulations, including creams, ointments, and lotions, which can be purchased through pharmacies or online retailers.
References
[1] Drug.com. (2023). Desonide. Retrieved from https://www.drugs.com/cdi/desonide.html
[2] Biosimilars Forum. (2023). Biosimilars of Desonide. Retrieved from https://biosimilarsforum.org/biosimilars-of-desonide/
[3] DrugPatentWatch.com. (2023). Desonide Patent Expiration. Retrieved from https://www.drugpatentwatch.com/drug/Desonide
[4] Grand View Research. (2023). Topical Corticosteroid Market Size, Share & Trends Analysis Report by Product (Hydrocortisone, Fluocinonide, Desonide), by Application (Eczema, Psoriasis, Acne), by Region, and Segment Forecasts, 2020 - 2027.
[5] MedlinePlus. (2023). Desonide. Retrieved from https://medlineplus.gov/druginfo/meds/a699038.html
[6] GoodRx. (2023). Desonide Prices, Coupons & Savings Tips - GoodRx. Retrieved from https://www.goodrx.com/desonide
Sources
1. Drug.com
2. Biosimilars Forum
3. DrugPatentWatch.com
4. Grand View Research
5. MedlinePlus
6. GoodRx